BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19605)

  • 1. Hallucinogen binding to dopamine/neuroleptic receptors.
    Whitaker PM; Seeman P
    J Pharm Pharmacol; 1977 Aug; 29(8):506-7. PubMed ID: 19605
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic receptors: stereoselectivity for neuroleptic enantiomers.
    Seeman P; Westman K; Protiva M; Jílek J; Jain PC; Saxena AK; Anand N; Humber L; Philipp A
    Eur J Pharmacol; 1979 Jun; 56(3):247-51. PubMed ID: 38971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain receptors for dopamine and neuroleptics.
    Seeman P; Titeler M; Tedesco J; Weinreich P; Sinclair D
    Adv Biochem Psychopharmacol; 1978; 19():167-76. PubMed ID: 29446
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine receptors, neuroleptics, and schizophrenia.
    Snyder SH
    Am J Psychiatry; 1981 Apr; 138(4):460-4. PubMed ID: 6111227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparkinsonian drug doses and neuroleptic receptors.
    Titeler M; Seeman P
    Experientia; 1978 Nov; 34(11):1490-2. PubMed ID: 720482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4354-8. PubMed ID: 12505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic/dopamine receptors: elevation and reversal.
    List S; Seeman P
    Adv Biochem Psychopharmacol; 1980; 24():95-101. PubMed ID: 6105811
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM; Mishra RK
    Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective labeling of apomorphine receptors by 3H-LSD.
    Whitaker PM; Seeman P
    Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased binding of [3H]apomorphine in caudate membranes after dopamine pretreatment in vitro.
    McManus C; Hartley EJ; Seeman P
    J Pharm Pharmacol; 1978 Jul; 30(7):444-7. PubMed ID: 27612
    [No Abstract]   [Full Text] [Related]  

  • 12. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.
    Creese I; Burt DR; Synder SH
    Life Sci; 1975 Dec; 17(11):1715-9. PubMed ID: 1207384
    [No Abstract]   [Full Text] [Related]  

  • 13. The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
    Höllt V; Czlonkowski A; Herz A
    Brain Res; 1977 Jul; 130(1):176-83. PubMed ID: 560239
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple dopamine binding sites: subcellular localization and biochemical characterization.
    Clement-Cormier YC; George RJ
    J Neurochem; 1979 Mar; 32(3):1061-9. PubMed ID: 430039
    [No Abstract]   [Full Text] [Related]  

  • 15. 3H-Apomorphine interactions with dopamine receptors in calf brain.
    Thal L; Creese I; Snyder SH
    Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.
    Enna SJ; Bennett JP; Burt DR; Creese I; Snyder SH
    Nature; 1976 Sep; 263(5575):338-41. PubMed ID: 8733
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective labeling of pre-synaptic receptors by 3H-dopamine, 3H-apomorphine and 3H-clonidine; labeling of post-synaptic sites by 3H-neuroleptics.
    Titeler M; Tedesco JL; Seeman P
    Life Sci; 1978 Aug; 23(6):587-91. PubMed ID: 29197
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine receptors in subcellular fractions from bovine caudate: enrichment of [3H]spiperone binding in a postsynaptic membrane fraction.
    Near JA; Mahler HR
    J Neurochem; 1981 Mar; 36(3):1142-51. PubMed ID: 7205263
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotic drug doses and neuroleptic/dopamine receptors.
    Seeman P; Lee T; Chau-Wong M; Wong K
    Nature; 1976 Jun; 261(5562):717-9. PubMed ID: 945467
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.